
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Vanderbilt-Ingram Cancer Center"
Count: 233
Selected: 0
NCT ID | Title |
---|
NCT01791478 | BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer | ||
NCT00474604 | Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants | ||
NCT02672475 | Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer | ||
NCT00898313 | Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer | ||
NCT03238248 | Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors | ||
NCT05770531 | Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy | ||
NCT04590404 | Metabolism Informed Smoking Treatment: The MIST RCT | ||
NCT02869633 | Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant | ||
NCT05901545 | Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer | ||
NCT05945875 | Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer | ||
NCT06074133 | A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules | ||
NCT05501665 | Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer | ||
NCT02658487 | Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia | ||
NCT05361720 | Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study | ||
NCT06140407 | Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer | ||
NCT06110572 | Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation | ||
NCT04506008 | Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas | ||
NCT04059393 | PCRC-Supported Legacy Intervention in Pediatric Palliative Care | ||
NCT05108805 | Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting | ||
NCT03206203 | Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer | ||
NCT04250194 | Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration | ||
NCT04763915 | Improving Care After Inherited Cancer Testing | ||
NCT06105801 | TBNA vs EBUS-TBNA Plus Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing | ||
NCT05919108 | Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers | ||
NCT00899301 | Collecting and Storing Tissue Samples From Women With or Without Breast Cancer | ||
NCT03181256 | Early Detection of Lung Cancer | ||
NCT04454476 | Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor | ||
NCT04883827 | Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer | ||
NCT03267381 | Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy | ||
NCT06016855 | Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors | ||
NCT02493530 | TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea | ||
NCT05996432 | Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy | ||
NCT02794428 | Chemoprevention of Gastric Carcinogenesis | ||
NCT03962647 | A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer | ||
NCT03583086 | Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors | ||
NCT03932786 | Studying Health Outcomes After Treatment in Patients With Retinoblastoma | ||
NCT02860039 | High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant | ||
NCT00897117 | Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer | ||
NCT03694249 | Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence | ||
NCT05764395 | Rigosertib Plus Pembrolizumab in Treating Patients With Unresectable/Metastatic Melanoma Refractory to PD-1 Inhibitors | ||
NCT04310345 | Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents | ||
NCT03179761 | High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients | ||
NCT03263429 | Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer | ||
NCT03238196 | Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer | ||
NCT04299425 | Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy | ||
NCT04281875 | Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. | ||
NCT04354701 | COVID-19 and Cancer Consortium Registry | ||
NCT03231891 | Inherited CAncer REgistry | ||
NCT02702310 | Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides | ||
NCT04327999 | Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System |